scholarly journals Tuberculosis in Children and Adolescents, Taiwan, 1996–2003

2007 ◽  
Vol 13 (9) ◽  
pp. 1361-1363 ◽  
Author(s):  
Pei-Chun Chan ◽  
Li-Min Huang ◽  
Yi-Chun Wu ◽  
Hsiang-Lin Yang ◽  
I-Shou Chang ◽  
...  
2017 ◽  
Vol 95 (6) ◽  
pp. 34-39 ◽  
Author(s):  
L. A. Bаryshnikovа ◽  
◽  
V. A. Аksenovа ◽  
N. I. Klevno ◽  
◽  
...  

PEDIATRICS ◽  
1960 ◽  
Vol 26 (4) ◽  
pp. 641-653
Author(s):  
A. Lotte ◽  
H. Noufflard ◽  
Robert Debrá ◽  
H. E. Brissaud

A preliminary inquiry of the Institut National d'Hygiéne (France), based on the follow-up of 5,526 cases of primary tuberculosis in children and adolescents, is reported; 1,425 cases were seen before 1955 and included in the statistical survey concluded in June, 1956. The spontaneous course of 895 patients who received no treatment is analyzed; special emphasis is placed on complications and their relative incidence in the different age groups and forms of primary tuberculosis. Comparative studies of treated and untreated cases were possible only in patients under 15 years of age and in clinically manifest forms of tuberculosis (Types II, III, and IV). These cases represent a total of 1,061 cases; 564 patients received treatment, 497 received no treatment. Findings in the different age groups are analyzed. A bacteriologic inquiry was also made on the problem of contamination with streptomycin- and isoniazid-resistant strains of M. tuberculosis and on secondarily acquired resistance to isoniazid in treated patients. A decrease of more than 80% in the incidence of complications led to the conclusion that routine chemotherapy should be resorted to in clinically manifest primary tuberculosis in children and adolescents. In the case of completely latent primary tuberculosis, however, a definite answer cannot be given as yet. It is the purpose of the future development of the trial to try to answer that question.


2020 ◽  
Vol 67 (8) ◽  
Author(s):  
Patricia Obando ◽  
David A. Verón ◽  
Mauricio Castellanos ◽  
Karen S. Fernández

2009 ◽  
Vol 28 (5) ◽  
pp. 416-419 ◽  
Author(s):  
Wanatpreeya Phongsamart ◽  
Ian Kitai ◽  
Michael Gardam ◽  
Jun Wang ◽  
Kamran Khan

2016 ◽  
Vol 11 (4) ◽  
pp. 9-17
Author(s):  
V.A. Aksenova ◽  
◽  
N.N. Moiseeva ◽  
N.I. Klevno ◽  
V.S. Odinets ◽  
...  

2021 ◽  
pp. 94-100
Author(s):  
E. S. Ovsyankina ◽  
L. V. Panova

Invasive technologies in the complex treatment of tuberculosis in children and adolescents have a long history, which began in the pre-antibiotic period. This is the way of their improvement from independent use of artificial pneumothorax and pneumoperitoneum to the use of these techniques in the complex treatment of respiratory tuberculosis during the development of chemotherapy for the disease. New technology uses valvular bronchial blocking. That procedure creates hypoventilation and atelectasis in the affected region of the lung with preservation of drainage function of the blocked bronchus and destruction cavity, which allow reducing indications for surgical treatment as a method with a high level of injury rate. The approaches to surgical intervention in children and adolescents with respiratory tuberculosis have also changed. It is also part of the comprehensive treatment of the disease. Minimally invasive accesses under the control of video-assisted thoracoscopy are used, which significantly reduced the risk of surgery and increased the immediate efficiency of surgical treatment. New technologies combined with all types of surgeries are being widely developed: electro- and argon plasma coagulation and pleurodesis, vaporization of the tuberculous lesion, and encapsulated pleura by high-energy CO2 laser, new materials (polypropylene implants) are used. Further development of invasive technologies with multiple and extensively drug-resistant Mycobacterium tuberculosis, to children and adolescents compensates for the lack of efficiency of conservative chemotherapy and is an urgent problem at the present stage of pediatric phthisiology.


Author(s):  
Vanessa Novaes Barros ◽  
Elisa Maria Novaes Barros ◽  
Luiza Oliveira Alvares ◽  
Mariana barbosa ◽  
Alan Vasconcelos Froes ◽  
...  

2020 ◽  
Vol 99 (6) ◽  
pp. 112-118
Author(s):  
Yu.P. Chugaev ◽  
◽  
N.G. Kamayeva ◽  
A.I. Tsvetkov ◽  
D.A. Kudlay ◽  
...  

Objective of the research: to assess the effect of recombinant tuberculosis allergen (RTA) in tuberculosis infection (TI) screening in children and adolescents on the epidemiological indicators of tuberculosis (TB) and to study the economic efficiency of using RTA in a large industrial region. Materials and methods: according to medical records, two periods were analyzed, 2011–2015 and 2016–2019, before and after the RTA screening introduction, respectively. Results: it was found that using RTA test in practice for the differential diagnosis of infectious and post-vaccination allergies led to an improvement in the epidemic situation among the child population and a significant economic effect – the savings during the year amounted to 12 385 407,84 rubles. RTA allows to reveal latent TI and develop scientific approaches to studying predictors of the clinically expressed TB, which is extremely important in modern conditions.


Sign in / Sign up

Export Citation Format

Share Document